-
reveal novel insights into chromatin dysregulation and identify therapeutic targets. We are particularly interested in applicants with a strong background (or keen interest in) chromatin biology
-
, to define novel biomarkers, and to identify novel therapeutical targets. We have pioneered in the integration of genetics with omic data to identify proteomic signatures and develop novel predictive models
-
dementias. The ultimate goal of the NGI is to understand the biology of these diseases, to define novel biomarkers, and to identify novel therapeutic targets. WashU Medicine is renowned for its research
-
and quantitative proteomics, phosphoproteomics, TMT, Cross-linking MS, targeted proteomics (PRM/SRM), and DIA analysis. Prior experience in one or more of these techniques is strongly preferred
-
genetic, biochemical and cell biology approaches to uncover novel host/parasite interactions that could be future targets for therapeutic intervention. Job Description Primary Duties & Responsibilities
-
the biological mechanisms underlying immune tolerance in HSCT. The laboratory has the additional goal of using a bench-to-bedside approach to develop novel cellular therapies for GVHD prevention and for targeting
-
pathogenesis that could be targeted to ameliorate the burden of viral diseases. Our multidisciplinary approach to gather an inclusive mechanistic understanding of the processes that result from the interaction
-
are dedicated to the development and application of innovative optical technologies aimed at understanding how social behavior is regulated in rodent brain. Our research targets psychiatric disorders such as
-
disease associated events that may serve as both therapeutic targets and biomarkers for early onset dementia such as early onset Alzheimer’s disease and frontotemporal dementia. Our research leverages